Cytokinetics | Eiendeler



Assets Endring Dato
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Amgen USD 89.37B 2.47B 2025-03
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Cytokinetics USD 1.4B 34.39M 2024-12
Eisai JPY 1.43T 111.45B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Exelixis USD 2.95B 12.59M 2025-01
Geron USD 593.78M 148.83M 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Ligand Pharmaceuticals USD 941.77M 13.09M 2024-12
Merck USD 115.12B 1.98B 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03



Cytokinetics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.